Showing 35,231 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP

Philippines trials anti-HIV drug as cases hit record high

Editor's pick
Thomson Reuters
27 July 2017
Global health targets

HIV treatment: Strategies to reach the next 10 million patients

Editor's pick
Devex
27 July 2017
Side effects

New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment

Editor's pick
Napo Pharmaceuticals press release
27 July 2017
Vaginal rings & topical PrEP

Dapivirine vaginal ring safe, acceptable for HIV prevention in teens

Editor's pick
Healio
27 July 2017
Self-testing & home testing

IAS 2017: UNITAID, partners boost HIV self-test access in six African countries

Editor's pick
Science Speaks
27 July 2017
Pregnancy and vertical transmission

Vertical HIV transmission may be influenced by complex synergies with other STI – such as Cytomegalovirus

Editor's pick
BMJ Group blogs
27 July 2017
Hepatitis & HIV

ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

Editor's pick
Eurekalert Inf Dis
27 July 2017
Vaginal rings & topical PrEP

Rectal products for PrEP: Are they an option?

Editor's pick
BETA blog
27 July 2017
The search for a cure

What can science learn from a child who has controlled HIV without drugs for more than 8 years?

Editor's pick
Science
27 July 2017
Injectable & long-acting PrEP

Long-acting cabotegravir injection shows promise for HIV prevention

News
27 July 2017
New & experimental HIV treatments

Doravirine combination pill looks good for initial HIV treatment

News
27 July 2017
Side effects

Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

News
27 July 2017
Access to healthcare

Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows

News
27 July 2017
PrEP

Update on PrEP Impact trial in England

Editor's pick
Gov.uk
26 July 2017
Circumcision

Medical male circumcision for HIV has benefits for women too

News
26 July 2017
PrEP

Demonstration projects explore the feasibility of PrEP for adolescents and young women in South Africa

News
26 July 2017
Drug-resistant TB

X-DR TB emerged in 1990s in South Africa fueled by HIV

Editor's pick
Science Speaks
26 July 2017
PrEP science

Ipergay trial: PrEP still protected people who had less sex and used it less often

News
26 July 2017
Vaginal rings & topical PrEP

IPM receives award of up to $25 million From USAID to advance HIV prevention products for women

Editor's pick
Eurekalert Medicine & Health
26 July 2017
The search for a cure

Antibody helps keep man's HIV at bay for 10 months

Editor's pick
BBC News
26 July 2017
The search for an HIV prevention vaccine

Another HIV vaccine efficacy trial will start this year

News
26 July 2017
New & experimental hepatitis C treatment

Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection

News
26 July 2017
Transgender people

Drug interaction concerns may negatively affect HIV treatment adherence among transgender women

Editor's pick
NIAID
25 July 2017
Men who have sex with men (MSM)

IAS 2017 highlights innovative approaches to overcome stigma and discrimination against key populations

Editor's pick
International AIDS Society
25 July 2017